News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

miRagen Therapeutics Expands Executive Team Adding Drug Development Veteran


4/24/2012 10:25:39 AM

BOULDER, Colo.--(BUSINESS WIRE)--MiRagen Therapeutics, Inc., a biopharmaceutical company developing innovative microRNA (miRNA)-based therapeutics primarily for the treatment of patients who suffer from cardiovascular and muscle disease, announced today that Dr. Arthur A. Levin has joined its executive team as Executive Vice President of Research and Development. In this role, Dr. Levin will be responsible for advancing miRagen’s current product candidates into development and for leading discovery research efforts aimed at expanding the company’s pipeline.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES